Login / Signup

Seroprevalence and risk factors of brucellosis in dromedary camels ( Camelus dromedarius ) in Sudan from 1980 to 2020: A systematic review and meta-analysis.

Abdullah A A MohammedMusa AhmedAhmed Osman AhmedSadam YousofSuad HamadYassir ShuaibNasir A Ibrahim
Published in: The veterinary quarterly (2023)
Camel brucellosis is a major public health concern in Sudan; however, there is no overall estimation of the prevalence of camel brucellosis in Sudan. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, this study aimed to perform a meta-analysis of 30 eligible studies published before December 31, 2022, with a total of 70059 dromedary camels, to estimate the pooled prevalence of camel brucellosis and its risk factors in Sudan. The random effect model was used for the final analysis due to the significantly high heterogeneity among the included studies, and the results showed that the overall pooled prevalence of camel brucellosis was 17%, with a confidence interval (CI) of 12%-21%. The prevalence was higher in males than females (54% vs. 46%) and in adults than youngling (77% vs. 23%). The prevalence also varied by region, with central and northern Sudan having the highest prevalence (24%), compared to other regions of Sudan. Moreover, the prevalence of camel brucellosis appeared to be decreasing over time. The current study concluded that camel brucellosis infection is still endemic in many areas of Sudan, with the disease being especially prevalent in central and northern Sudan. Thus, this study provides valuable information for the prevention and control of camel brucellosis in Sudan. However, the significant heterogeneity among the included studies should be taken into account when interpreting these results. Finally, to provide adequate information, research must be updated, and more research must be conducted in many regions of Sudan.
Keyphrases
  • risk factors
  • public health
  • systematic review
  • meta analyses
  • healthcare
  • clinical trial
  • single cell
  • social media
  • health information
  • case control
  • electronic health record
  • adverse drug
  • data analysis